MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202627000822 A) filed by Navinta, LLC on January 05, 2026, for Stable Solid Oral Formulation Of Tafamidis Or Pharmaceutically Acceptable Salt Thereof.
Inventors include Mansuri, Niyaz Sultanbhai; Patel, Mahendra R.; Patel, Bhavik Rajendrakumar; and Pandya, Kartik.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: The present invention relates to a solid oral powder filled hard gelatin capsule formulation of tafamidis, a pharmaceutically acceptable salt thereof, or tafamidis co- crystal(s), which involves use of standard dry blending ingredients and provides an improved dissolution profile. The formulation includes an effective amount of tafamidis, a pharmaceutically acceptable salt thereof, or a tafamidis co-crystal(s), at least one solubilizing agent; and at least one excipient selected from diluent, disintegrant and lubricant.
Disclaimer: Curated by HT Syndication.
